Boardroom Alpha
Meeting calendar
IMAX · Annual meeting · Wednesday, June 10, 2026

Imax Corp

10 nominees · 3 ballot items.

Elect ten directors; appoint PricewaterhouseCoopers LLP as independent auditors and authorize directors to fix their remuneration; and conduct an advisory (non-binding) vote to approve Named Executive Officer compensation as disclosed in the proxy.

Market cap
$2.2B
1Y TSR
+48.7%
Board grade
B-
Record date
Apr 13, 2026
Filing
DEF 14A
Meeting concluded · Jun 10, 2026

Follow how the vote landed and what changed on Imax Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of the Ten Nominees for the Board of Directors

    ManagementBoard: FOR

    Elect ten individuals nominated to serve as directors until the close of the next annual general meeting or until their successors are elected or appointed.

  2. 2

    Appointment of PricewaterhouseCoopers LLP as the Company's Independent Auditors

    ManagementBoard: FOR

    Approve the appointment of PricewaterhouseCoopers LLP as the Company's independent auditors until the next annual general meeting and authorize the directors to fix the auditors’ remuneration.

  3. 3

    Advisory Vote on Named Executive Officer Compensation ("Say-on-Pay

    ManagementBoard: FOR

    Advisory (non-binding) vote to approve the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis, compensation tables, and related narrative in the proxy.

    More detail

    This advisory proposal asks shareholders to approve, on a non-binding basis, the Company’s executive compensation program as described in the Compensation Discussion and Analysis and related disclosure. Management seeks this endorsement to validate its pay-for-performance framework, which mixes short-term cash incentives and long-term equity (PSUs and RSUs) tied to quantitative metrics (Total Revenue, Installations, Total Adjusted EBITDA Growth and Margin, Signings, Adjusted EPS, and Relative TSR) and qualitative business-unit and individual assessments. The Compensation Committee emphasizes robust shareholder engagement — contacting holders of ~67% of shares in 2025 and reporting broad support, including 95% approval at the 2025 meeting — and says it has incorporated feedback (for example, adding Adjusted EPS to the annual bonus scorecard). In 2025 pay outcomes were above-target (annual bonuses paid at 119%–158% of target and 2023 PSUs paid at 165% of target) reflecting record company performance (record box office, revenue, margin expansion, and network growth). Management also recently amended the CEO’s employment agreement to increase his equity grant opportunity (delivered in long-term incentives) and to align certain vesting/service provisions, which the Board presents as reinforcing long-term alignment despite legacy change‑in‑control terms that remain. The vote is non-binding, but the Board and Compensation Committee state they will review results and consider shareholder views in future decisions. For an investor evaluating the proposal, key considerations include the demonstrated strong company performance and high historical shareholder support, the alignment of pay to multi-year performance via PSUs and TSR-relative measures, the recent increase in CEO long-term pay (higher equity target and PSU maximum), and governance signals such as shareholder outreach and clawback and anti-hedging policies; potential concerns include the retention of certain legacy change-in-control provisions for the CEO and the discretion in qualitative bonus components. Overall, the Board frames the proposal as a confirmation of a compensation program that has delivered significant shareholder value while preserving flexibility to retain and incentivize required executive talent.

Director elections

Nominees on the ballot10

Independent
Tenure on this board
3.4 yrs
Also a director at
Capital One Financial Corp (COF)
Ownership

Top institutional holders10

Latest 13F quarter
1Orbis Allan Gray Ltd9.4%5,131,901$195M
2NOMURA ASSET MANAGEMENT INTERNATIONAL INC.6.8%3,704,207$141M
3WESTFIELD CAPITAL MANAGEMENT CO LP4.3%2,338,776$89M
4DRIEHAUS CAPITAL MANAGEMENT LLC3.0%1,651,711$63M
5BlackRock, Inc.2.8%1,563,089$59M
6CONGRESS ASSET MANAGEMENT CO2.8%1,510,375$57M
7FMR LLC2.7%1,461,735$56M
8AMERIPRISE FINANCIAL INC2.3%1,247,141$47M
9ROYCE ASSOCIATES LP2.3%1,246,240$47M
10DIMENSIONAL FUND ADVISORS LP2.1%1,170,744$44M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Imax Corp 2026 annual meeting?
Imax Corp (IMAX) holds its 2026 annual shareholder meeting on Wednesday, June 10, 2026.
What is the record date for the Imax Corp 2026 meeting?
The record date for the Imax Corp 2026 meeting is Monday, April 13, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Imax Corp's 2026 meeting?
The board is presenting 10 director nominees at the Imax Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Imax Corp 2026 meeting?
Shareholders will vote on 3 proposals at the Imax Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer